Consolidated Statements Of Earnings (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Revenues	$ 638,197		$ 259,561
Provision for uncollectibles	(73,999)		(5,216)
Net revenue	570,445		259,561
Operating expenses:
Salaries and benefits	302,179		82,149
Supply cost	42,584		37,805
Other operating expenses	90,570		54,169
Transaction costs	1,471		0
Depreciation and amortization	22,818		8,259
Total operating expenses	459,622		182,382
Gain (loss) on deconsolidation	(223)		2,045
Equity in earnings of unconsolidated affiliates	2,651		764
Operating income	113,251		79,988
Interest expense, net	30,247		6,960
Earnings from continuing operations before income taxes	83,004		73,028
Income tax expense	14,249		12,982
Net earnings from continuing operations	68,755		60,046
Net earnings from discontinued operations	0		68
Net earnings	68,755		60,114
Less net earnings attributable to noncontrolling interests	47,717		42,919
Net earnings attributable to AmSurg Corp. shareholders	21,038		17,195
Preferred stock dividends	(2,264)		0
Net earnings attributable to AmSurg Corp. common shareholders	18,774		17,195
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	18,774		17,392
Loss from discontinued operations, net of income tax	0		(197)
Net earnings attributable to AmSurg Corp. common shareholders	18,774		17,195
Basic earnings per share attributable to AmSurg Corp. common shareholders:
Net earnings (loss) from continuing operations (usd per share)	$ 0.39		$ 0.55
Net earnings (loss) from discontinued operations (usd per share)	$ 0.00		$ (0.01)
Net earnings (loss) (usd per share)	$ 0.39		$ 0.54
Diluted earnings per share attributable to AmSurg Corp. common shareholders:
Net earnings (loss) from continuing operations (usd per share)	$ 0.39		$ 0.54
Net earnings (loss) from discontinued operations (usd per share)	$ 0.00		$ (0.01)
Net earnings (loss) (usd per share)	$ 0.39		$ 0.54
Weighted average number of shares and share equivalents outstanding:
Basic (in shares)	47,572		31,716
Diluted (in shares)	47,905		32,120
Physician Services [Member]
Provision for uncollectibles	(67,752)	[1]	0
Net revenue	$ 286,535	[1]	$ 0

[1] On July 16, 2014, we completed the acquisition of Sheridan. As such, historical amounts for periods prior to that date are not included.